National, Longitudinal, Multicentre and Prospective, Observational Study of the Use of Micafungin (Mycamine) in Antifungal Prophylaxis of Invasive Fungal Infections in Medical Practice in Haematology and Onco-haematology
Phase of Trial: Phase IV
Latest Information Update: 25 Jun 2017
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- Acronyms OLYMPE
- Sponsors Astellas Pharma
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association.
- 01 Jun 2016 Status changed from recruiting to completed.
- 09 Jul 2015 Planned End Date changed from 1 Oct 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.